Humanco Acquisition Corp.
HMCOW
NASDAQ Capital Market0.00
USD
- -
- -
CIK
0001829042
Return %
Stock
S&P500
1Y
-99.95
26.53
3Y
-99.99
76.60
5Y
-99.99
80.11
Capital Structure
FRC
•
in mil. unless spec.Working Capital
FRC
•
in mil. unless spec.Growth Rates
FRC
•
in mil. unless spec.Quarterly Revenue
FRC
•
in mil. unless spec.Quarterly Earnings Per Share
FRC
•
in mil. unless spec.Quarterly Dividends Per Share
FRC
•
in mil. unless spec.- Sector
- Financial Services
- Industry
- Shell Companies
- Address
- IPO Date
- Feb 1, 2021
- CIK
- 0001829042
- Similar Companies
- Business
- Humanco Acquisition Corp. (HMCOW) operates as a blank check company whose primary purpose is to effect a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses or assets, with a focus on the health and wellness ecosystem. The company does not have significant independent operations and targets opportunities in industries complementing its management team's expertise in consumer goods and health-related sectors within the United States. Founded in 2020 and headquartered in Austin, Texas, it maintains its strategic emphasis on building or investing in companies that promote healthier living. The company's core activities center on identifying and pursuing business combinations in health and wellness, including potential targets in sustainable consumer products, personal care, and related fields; it generates no current revenue from products or services but holds proceeds from its initial public offering for deployment in a de-SPAC transaction. Geographically, Humanco Acquisition Corp. concentrates on U.S.-based opportunities, aligning with its management's background in domestic consumer markets. In recent developments, the company announced its intention to dissolve and liquidate in late 2022 after failing to complete an initial business combination within its mandated timeframe, marking a significant operational wind-down; its units and warrants continue to trade on over-the-counter markets as residual securities. Affiliates, including HumanCo Investments, have pursued separate strategic engagements such as a 2022 partnership with Grove Collaborative involving up to $100 million in potential funding for M&A opportunities in sustainable consumer goods, as well as activist campaigns in 2025 urging strategic reviews or sales of related assets. No merger or acquisition has been consummated by Humanco Acquisition Corp. itself as of the latest available information.